Hypomethylating agents for patients with VEXAS without myelodysplastic syndrome: Clinical outcome and longitudinal follow-up of vacuolization and UBA1 clonal dynamics BRIT J HAEMATOL
Lifetime Treatment Trajectories of Mantle Cell Lymphoma: Simulation Based Analysis of 20 Years of Real-World Data Hematol Oncol
Pomalidomide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Survival and Subgroup Analyses From the OPTIMISMM Trial Eur J Haematol
Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study Eur J Cancer
A novel human pluripotent stem cell gene activation system identifies IGFBP2 as a mediator in the production of haematopoietic progenitors in vitro Elife
Direct Interaction Between CD34(+) Hematopoietic Stem Cells and Mesenchymal Stem Cells Reciprocally Preserves Stemness CANCERS
Socioeconomic inequalities in adherence to clinical practice guidelines and breast cancer survival: a multicentre population-based study in Spain BMJ Qual Saf
The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045 JNCI-J NATL CANCER I